为您找到相关结果约259个

你是不是要搜索 期刊Navitoclax 点击跳转

Navitoclax Most Promising BH3 Mimetic for Combination Therapy in Hodgkin Lymphoma

Senolytic Agent Navitoclax Inhibits Angiotensin II-Induced Heart Failure in Mice

Transient metabolic improvement in obese mice treated with navitoclax or dasatinib/quercetin

Clearance of senescent cells by navitoclax (ABT263) rejuvenates UHMWPE-induced osteolysis

THERAPEUTIC POTENTIAL OF NAVITOCLAX IN AGE RELATED CARDIOVASCULAR DISEASES

Multi-Omics Investigation of Innate Navitoclax Resistance in Triple-Negative Breast Cancer Cells

Navitoclax combined with Alpelisib effectively inhibits Merkel cell carcinoma cell growth in vitro

CDK5 Inhibitor Downregulates Mcl-1 and Sensitizes Pancreatic Cancer Cell Lines to Navitoclax

Idasanutlin and navitoclax induce synergistic apoptotic cell death in T-cell acute lymphoblastic leukemia

Dasatinib and navitoclax act synergistically to target NUP98-NSD1(+)/FLT3-ITD+ acute myeloid leukemia

Navitoclax improves acute-on-chronic liver failure by eliminating senescent cells in mice

MUC1 Aptamer-Capped Mesoporous Silica Nanoparticles for Navitoclax Resistance Overcoming in Triple-Negative

Polylactic acid based polymeric nanoparticle mediated co-delivery of navitoclax and decitabine for cancer

Selective Targeting of Cancer-Associated Fibroblasts by Engineered H-Ferritin Nanocages Loaded with Navitoclax

MCL1 inhibitors S63845/MIK665 plus Navitoclax synergistically kill difficult-to-treat melanoma cells

为您找到相关结果约259个

共259条页码: 1/18页15条/页